Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

Shiow LR, Rosen DB, Brdicková N, Xu Y, An J, Lanier LL, Cyster JG, Matloubian M.

Nature. 2006 Mar 23;440(7083):540-4. Epub 2006 Mar 8.

PMID:
16525420
2.

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.

Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG.

Nature. 2004 Jan 22;427(6972):355-60.

PMID:
14737169
3.

Finding a way out: lymphocyte egress from lymphoid organs.

Schwab SR, Cyster JG.

Nat Immunol. 2007 Dec;8(12):1295-301.

PMID:
18026082
4.

Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.

Matsuyuki H, Maeda Y, Yano K, Sugahara K, Chiba K, Kohno T, Igarashi Y.

Cell Mol Immunol. 2006 Dec;3(6):429-37.

5.

Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.

Srinivasan S, Bolick DT, Lukashev D, Lappas C, Sitkovsky M, Lynch KR, Hedrick CC.

Diabetes. 2008 Feb;57(2):484-93. Epub 2007 Nov 14.

6.
7.

Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-beta.

Gao Y, Majchrzak-Kita B, Fish EN, Gommerman JL.

Blood. 2009 Sep 24;114(13):2623-31. doi: 10.1182/blood-2008-10-183301. Epub 2009 Aug 3.

8.

Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.

Chiba K, Matsuyuki H, Maeda Y, Sugahara K.

Cell Mol Immunol. 2006 Feb;3(1):11-9. Review.

9.
10.

Depletion of T cells by type I interferon: differences between young and aged mice.

Jiang J, Gross D, Nogusa S, Elbaum P, Murasko DM.

J Immunol. 2005 Aug 1;175(3):1820-6.

11.

Protein kinase C epsilon dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes.

Graeler MH, Kong Y, Karliner JS, Goetzl EJ.

J Biol Chem. 2003 Jul 25;278(30):27737-41. Epub 2003 Jun 2.

12.

Specifying the patterns of immune cell migration.

Cyster JG.

Novartis Found Symp. 2007;281:54-61; discussion 61-4, 208-9. Review.

PMID:
17534065
13.

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.

Sanna MG, Wang SK, Gonzalez-Cabrera PJ, Don A, Marsolais D, Matheu MP, Wei SH, Parker I, Jo E, Cheng WC, Cahalan MD, Wong CH, Rosen H.

Nat Chem Biol. 2006 Aug;2(8):434-41. Epub 2006 Jul 9.

PMID:
16829954
15.

Distribution of cycling T lymphocytes in blood and lymphoid organs during immune responses.

Vasseur F, Le Campion A, Pavlovitch JH, Pénit C.

J Immunol. 1999 May 1;162(9):5164-72.

16.
17.

Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.

Johnson J, Albarani V, Nguyen M, Goldman M, Willems F, Aksoy E.

J Biol Chem. 2007 May 18;282(20):15022-32. Epub 2007 Feb 12.

18.

Sphingosine 1-phosphate 1 and TLR4 mediate IFN-beta expression in human gingival epithelial cells.

Eskan MA, Rose BG, Benakanakere MR, Lee MJ, Kinane DF.

J Immunol. 2008 Feb 1;180(3):1818-25.

19.

Egress: a receptor-regulated step in lymphocyte trafficking.

Rosen H, Sanna G, Alfonso C.

Immunol Rev. 2003 Oct;195:160-77. Review.

PMID:
12969317
20.

FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.

Hofmann M, Brinkmann V, Zerwes HG.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1902-10. Epub 2006 Aug 30.

PMID:
17161343

Supplemental Content

Support Center